Exhibits
10-K
from 10-K
151 pages
10-K
03/14/22
EX-3.1
from 10-K
18 pages
Delaware the First State Page 1 3444819 8100x Authentication: 202854145 Sr# 20220916489 Date: 03-08-22 You May Verify This Certificate Online at CORP.DELAWARE.GOV/AUTHVER.SHTML I, Jeffrey W. Bullock, Secretary of State of the State of Delaware, Do Hereby Certify the Attached Are True and Correct Copies of All Documents Filed From and Including the Restated Certificate or a Merger With a Restated Certificate Attached of “AVEO Pharmaceuticals, Inc.” as Received and Filed in This Office. the Following Documents Have Been Certified: Restated Certificate, Filed the Seventeenth Day of March, A.D. 2010, at 8 O`clock A.M. Certificate of Amendment, Filed the Twenty-Eighth Day of May, A.D. 2015, at 5 O`clock P.M. Certificate of Amendment, Filed the Twenty-Sixth Day of June, A.D. 2017, at 8:33 O`clock A.M. Certificate of Amendment, Filed the Thirteenth Day of June, A.D. 2019, at 11:47 O`clock A.M. Certificate of Amendment, Filed the Nineteenth Day of February, A.D. 2020, at 8:20 O`clock A.M. Delaware the First State Page 2 3444819 8100x Authentication: 202854145 Sr# 20220916489 Date: 03-08-22 You May Verify This Certificate Online at CORP.DELAWARE.GOV/AUTHVER.SHTML
03/14/22
EX-10.19
from 10-K
2 pages
Material contract
03/14/22
EX-10.20
from 10-K
13 pages
Severance and Change in Control Agreement
03/14/22
EX-10.21
from 10-K
4 pages
November 12, 2021 Compensation: •base Salary. Your Base Salary Will Be at the Annualized Rate of $450,000 Paid Semi-Monthly in Accordance With the Company's Standard Payroll Practices
03/14/22
EX-10.22
from 10-K
15 pages
Severance and Change in Control Agreement . This Severance and Change in Control Agreement (The "Agreement"), Made This
03/14/22
EX-10.23
from 10-K
12 pages
AVEO Pharmaceuticals, Inc. Executive Severance and Change in Control Benefits Plan
03/14/22
EX-10.24
from 10-K
5 pages
Non-Competition and Non-Solicitation Agreement
03/14/22
EX-10.32
from 10-K
42 pages
Agreement
03/14/22
EX-10.39
from 10-K
68 pages
License Agreement by and Between Eusa Pharma (Uk) Limited and AVEO Pharmaceuticals, Inc Dated: December 18, 2015
03/14/22
EX-10.47
from 10-K
5 pages
First Amendment to Sublease Agreement 30 Winter Street Boston, Massachusetts
03/14/22
EX-10.48
from 10-K
8 pages
Revocable Temporary License Agreement This Revocable Temporary License Agreement
03/14/22
EX-21.1
from 10-K
1 page
Subsidiaries of the registrant
03/14/22
EX-23.1
from 10-K
1 page
Consent of expert or counsel
03/14/22
EX-31.1
from 10-K
1 page
Management certification of annual or quarterly disclosure
03/14/22
EX-31.2
from 10-K
1 page
Management certification of annual or quarterly disclosure
03/14/22
EX-32.1
from 10-K
1 page
Management certification of financial report
03/14/22
EX-32.2
from 10-K
1 page
Management certification of financial report
03/14/22
Graphics & Data Files
GRAPHIC
from 10-K
aveo20211231ex31001.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31002.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31003.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31004.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31005.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31006.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31007.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31008.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31009.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31010.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31011.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31012.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31013.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31014.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31015.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31016.jpg
03/14/22
GRAPHIC
from 10-K
aveo20211231ex31017.jpg
03/14/22
GRAPHIC
from 10-K
image_0.jpg
03/14/22
GRAPHIC
from 10-K
image_01.jpg
03/14/22
GRAPHIC
from 10-K
image_03.jpg
03/14/22
GRAPHIC
from 10-K
image_04.jpg
03/14/22
GRAPHIC
from 10-K
image_1.jpg
03/14/22
